| |
|
| |
| Links: |
Spinal stenosis is narrowing of the spinal column and mainly occurs from a combination of aging and degenerative changes in the spine. This puts pressure on the spinal cord and the spinal nerve roots, and may cause pain, numbness, or weakness in the legs. Spinal stenosis mostly affects people above 60 years of age but can also occur in younger people born with the abnormal spinal canal. Lumbar spinal stenosis, cervical spinal stenosis and thoracic spinal stenosis are the three main types of spinal stenosis. About 75% of the cases of spinal stenosis occurs in the lower lumbar region. The primary symptoms associated with spinal stenosis are radiculopathy and myelopathy. Myelopathy is of greater concern as pressure on the spinal cord can lead to permanent spinal cord damage. Diagnosis of spinal stenosis involves the complete evaluation of spine. The most common diagnostic test for spinal stenosis are MRI scan and X-ray. In some cases CT scan can be conducted in order to diagnose the condition. Spinal stenosis treatment can be conservative or surgical depending upon the severity of the disease.
Spinal Stenosis Market: Drivers and Restraints
Increasing prevalence of degenerative spondylolisthesis and degenerative scoliosis among rapidly ageing population, rising number of obese population suffering from spine deformities, and rising demand for minimally invasive spine surgery procedures are the key factors fueling the growth of the global spinal stenosis market. However, high cost of treatment procedure, stringent product approval process and unclear reimbursement policies are the prime factors expected to hamper the global spinal stenosis market growth.
Spinal Stenosis Market: Segmentation
The global spinal stenosis market is segmented based on product type, treatment type end user and region.
Based on Product Type
Thoracic Fusion and Lumbar Fusion Devices
Anterior Thoracic and Lumbar Fusion Devices
Posterior Thoracic and Lumbar Fusion Devices
Interbody Thoracic and Lumbar Fusion Devices
Cervical Fusion Devices
Anterior Cervical Fusion Devices
Posterior Cervical Fusion Devices
Request Sample Report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-1388
Based on treatment type
Surgical treatment
Discectomy
Laminectomy
Foraminotomy
Facetectomy
Corpectomy
Non-Surgical Treatment
Based on end user type
Hospitals
Ambulatory Surgical centers
Rehabilitation Centers
Spinal Stenosis Market: MarketOverview
Numerous prescription medications are available to cure spinal stenosis. Epidural steroid injections and anti-inflammatory medications may be used to in case of acute spinal stenosis. Such nonsurgical treatments offer ways to control symptoms and enable you to improve without surgery. Whereas patients with chronic spinal stenosis opt for surgical procedures such as laminectomy, corpectomy foraminotomy and others. Due to rapidly ageing population and increasing prevalence of osteoarthritis, rheumatoid arthritis and spondylolisthesisare expected fuel the market value of global Spinal Stenosis market over the forecasted period.
Spinal Stenosis Market: Region-wise Overlook
Geographically, North America is expected to dominate the global spinal stenosis market followed by Europe owing to increase in number of aging population. This increase in the base of geriatric population is expected to result in rising prevalence of spinal disorders such as herniated discs and osteoarthritis. In addition, ready availability of skilled healthcare professionals would significantly lead to increase in number of surgical procedures thereby driver the growth of spinal stenosis market during the forecast period. However, lack of adequate physician and patient awareness/education about newly developed treatment procedures and technologies and high pricing pressure on market players are other factors hampering market growth. Asia-Pacific is expected to exhibit strongest growth dynamics in spinal stenosis market due to rising economic affluence in various parts of this region.
Request to View TOC @ https://www.futuremarketinsights.com/toc/rep-gb-1388
Spinal Stenosis Market: Key Players
Key companies operational in global spinal stenosis market are Medtronic Inc., DePuy Synthes, Stryker Corporation, Orthofix International N.V., NuVasive, Inc., Zimmer Biomet Holdings, Inc., Globus Medical, Inc., Alphatec Holdings, Inc., K2M Group Holdings, Inc., and LDR Holding Corporation.
(Added: Fri Jan 25 2019 Hits: 1 Rating: 0.00 Votes: 0) Rate ItFuture Market Insights presents a new report titled ‘Hepatitis B Diagnostic Tests Market: Global Industry Analysis 2012 – 2016 and Opportunity Assessment 2017 – 2027’ that studies the performance of the global hepatitis B diagnostic tests market over a 10 year assessment period from 2017 to 2027. The report presents the value forecasts of the global hepatitis B diagnostic tests market and provides pertinent insights into the factors driving market growth as well as the factors restricting market growth. As per the figures provided by Future Market Insights, the global hepatitis B diagnostic tests market was estimated to be valued at nearly US$ 650 Mn in 2017 and is likely to reach a valuation of nearly US$ 1,200 Mn in 2027 and in the process exhibit a CAGR of 6.3% during the period of forecast 2017-2027.
High Prevalence of Hepatitis B in the APEJ Region Boosting Global Market Revenue Growth
The prevalence of hepatitis B is highest in the APEJ region and the disease burden caused by chronic cases of hepatitis B is enormous. APEJ region has more number of chronic hepatitis B patients than any other region in the world and is thus a potential market for hepatitis B test kit manufacturers. As per the data provided by WHO, China accounts for one-third of all chronic hepatitis B infections. In addition, 6.2% of the adult population in the Western Pacific region is infected with hepatitis B. In the South-East Asia region, an estimated 2% of the general population is infected with hepatitis B. According to Hepatitis Australia, approximately 225,000 people are living with chronic hepatitis B in the country. As per the data provided by WHO, in India, the prevalence of hepatitis B surface antigen is 3%-4.2% with over 40 million hepatitis B carriers. Due to such high prevalence of hepatitis B in the APEJ region, the market for hepatitis B diagnostic tests has a huge potential in the region.
Request Sample Report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-1332
Global Hepatitis B Diagnostic Tests Market: Segmentation and Forecast
The global hepatitis B diagnostic tests market is segmented on the basis of product type, end user and region.
On the basis of product type, the enzyme immunoassay kits segment was estimated to be valued at nearly US$ 590 Mn in the year 2017 and is likely to reach a valuation of nearly US$ 1,100 Mn in 2027, accounting for a CAGR of 6.2% during the assessment period 2017-2027.
On the basis of end user, the hospitals segment was estimated to be valued at nearly US$ 250 Mn in 2017 and is estimated to reach a valuation of nearly US$ 460 Mn in 2027, registering a CAGR of 6.1% during the period of assessment.
On the basis of region, the APEJ hepatitis B diagnostic tests market was estimated to be valued at nearly US$ 200 Mn in 2017 and is likely to reach a valuation of nearly US$ 380 Mn in 2027, accounting for a CAGR of 7.2% during the period of forecast.
Request to View TOC @ https://www.futuremarketinsights.com/askus/rep-gb-1332
Global Hepatitis B Diagnostic Tests Market: Competitive Landscape
This report features some of the important players functioning in the global hepatitis B diagnostic tests market such as bioMérieux SA, Bio-Rad Laboratories, Inc., DiaSorin S.p.A., Abbott Laboratories, Meridian Bioscience, Inc., Vista Diagnostics International, Biogate Laboratories Ltd., J.Mitra & Co. Ltd., Siemens Medical Solutions USA, Inc. and General Biologicals Corporation.
(Added: Fri Jan 25 2019 Hits: 1 Rating: 0.00 Votes: 0) Rate ItPages: [<<] ... 238 239 240 241 242 243 244 245 246 247 248 249 250 251 252 ... [>>]
Links SQL By: Gossamer Threads Inc.